International Clinical Trial: Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07456826) titled 'Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Outcomes Assessor).

Primary Sponsor: Harrow Inc

Condition: Diabetic Macular Edema (DME) Age-Related Macular Degeneration (AMD) Retinal Vein Occlusion Diabetic Retinopathy (DR)

Intervention: Drug: Chloroprocaine Ophthalmic Gel 3% (IHEEZO) P...